Italy-based Istituto Nazionale Tumori Fondazione G. Pascale has entered into an initial launch and training agreement with Delcath Systems.
Under the agreement, Delcath will provide logistics and clinical training support to G. Pascale during performing chemosaturation therapy using the Chemosat system.
The agreement also allows the center to expand the presence of Chemosat delivery system in Naples, Italy.
Istituto Nazionale Tumori Fondazione G. Pascale department of melanoma, soft tissues, musculo-skeletal, head and neck director Ascierto said Chemosat has the potential to meet an unmet treatment need for patients at center.
"We anticipate that the delivery system will help us tremendously in the clinical setting," Ascierto added.